Cargando…
miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma
An increasing number of microRNAs have been found to be involved in tumorigenesis, including melanoma tumorigenesis. miR-204-5p is down-regulated and functions as a tumor suppressor in many human malignant tumors. miR-204-5p expression is also decreased in melanoma tissues, but its biological roles...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338948/ https://www.ncbi.nlm.nih.gov/pubmed/28280358 http://dx.doi.org/10.2147/OTT.S128819 |
_version_ | 1782512589909000192 |
---|---|
author | Luan, Wenkang Qian, Yao Ni, Xin Bu, Xuefeng Xia, Yun Wang, Jinlong Ruan, Hongru Ma, Shaojun Xu, Bin |
author_facet | Luan, Wenkang Qian, Yao Ni, Xin Bu, Xuefeng Xia, Yun Wang, Jinlong Ruan, Hongru Ma, Shaojun Xu, Bin |
author_sort | Luan, Wenkang |
collection | PubMed |
description | An increasing number of microRNAs have been found to be involved in tumorigenesis, including melanoma tumorigenesis. miR-204-5p is down-regulated and functions as a tumor suppressor in many human malignant tumors. miR-204-5p expression is also decreased in melanoma tissues, but its biological roles and molecular mechanisms in malignant melanoma remain unclear. In this study, the aberrant down-regulation of miR-204-5p was detected in melanoma, especially in metastatic melanoma. miR-204-5p also served as a protective factor for the prognosis of melanoma patients. We determined that miR-204-5p suppresses cell proliferation, migration and invasion, and promotes cell apoptosis in melanoma. Matrix metalloproteinases-9 and B-cell lymphoma-2 are the functional targets of miR-204-5p, through which it plays an important biological role in malignant melanoma. The effect of miR-204-5p on malignant melanoma is verified using a xenograft model. We also determined that miR-204-5p increases 5-fluorouracil and cisplatin (DDP) chemosensitivity in malignant melanoma cells. This finding elucidates new functions and mechanisms for miR-204-5p in melanoma development, and provides potential therapeutic targets for the treatment of melanoma. |
format | Online Article Text |
id | pubmed-5338948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53389482017-03-09 miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma Luan, Wenkang Qian, Yao Ni, Xin Bu, Xuefeng Xia, Yun Wang, Jinlong Ruan, Hongru Ma, Shaojun Xu, Bin Onco Targets Ther Original Research An increasing number of microRNAs have been found to be involved in tumorigenesis, including melanoma tumorigenesis. miR-204-5p is down-regulated and functions as a tumor suppressor in many human malignant tumors. miR-204-5p expression is also decreased in melanoma tissues, but its biological roles and molecular mechanisms in malignant melanoma remain unclear. In this study, the aberrant down-regulation of miR-204-5p was detected in melanoma, especially in metastatic melanoma. miR-204-5p also served as a protective factor for the prognosis of melanoma patients. We determined that miR-204-5p suppresses cell proliferation, migration and invasion, and promotes cell apoptosis in melanoma. Matrix metalloproteinases-9 and B-cell lymphoma-2 are the functional targets of miR-204-5p, through which it plays an important biological role in malignant melanoma. The effect of miR-204-5p on malignant melanoma is verified using a xenograft model. We also determined that miR-204-5p increases 5-fluorouracil and cisplatin (DDP) chemosensitivity in malignant melanoma cells. This finding elucidates new functions and mechanisms for miR-204-5p in melanoma development, and provides potential therapeutic targets for the treatment of melanoma. Dove Medical Press 2017-02-27 /pmc/articles/PMC5338948/ /pubmed/28280358 http://dx.doi.org/10.2147/OTT.S128819 Text en © 2017 Luan et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Luan, Wenkang Qian, Yao Ni, Xin Bu, Xuefeng Xia, Yun Wang, Jinlong Ruan, Hongru Ma, Shaojun Xu, Bin miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma |
title | miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma |
title_full | miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma |
title_fullStr | miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma |
title_full_unstemmed | miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma |
title_short | miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma |
title_sort | mir-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and b-cell lymphoma-2 in malignant melanoma |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338948/ https://www.ncbi.nlm.nih.gov/pubmed/28280358 http://dx.doi.org/10.2147/OTT.S128819 |
work_keys_str_mv | AT luanwenkang mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma AT qianyao mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma AT nixin mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma AT buxuefeng mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma AT xiayun mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma AT wangjinlong mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma AT ruanhongru mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma AT mashaojun mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma AT xubin mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma |